![]() |
| |
Elderly patients warned of Zyprexa risks- April 12, 2005 The FDA said yesterday that elderly patients with dementia were significantly more likely to die prematurely if taking certain anti-psychotic drugs. Included in the latest drug warning are schizophrenia and mania drugs Abilify, Zyprexa, Seroquel, Risperdal, Clozaril and Geodon. Symbyax is also included in the advisory, approved for the treatment of depression associated with bipolar disorder. The FDA asked the drug makers to add a boxed warning to the products, highlighting the risks and noting the drugs are not approved to treat dementia in the elderly. An FDA analysis of 17 studies covering four drugs showed the death rate for the elderly patients taking them was about 1.6 to 1.7 times the death rate for patients taking a placebo. If you believe that you or a loved one has suffered an injury or death as a result of Zyprexa call the Zyprexa lawyers of VanDerGinst Law. P.C. at (877) 786-1LAW (877-786-1529) or submit the free online case evaluation. The initial consultation is free of charge. If we agree to handle your Zyprexa case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please contact our Zyprexa lawyers right away to ensure that you do not waive your right to possible compensation. We can tell you if you have a case for a potential Zyprexa lawsuit. |
This site is not affiliated or connected
with ZYPREXA® or Eli Lilly. Zyprexa® is a registered trademark
of Eli Lilly and Company. © Copyright 2005 – VanDerGinst Law, P.C., personal
injury attorneys, MegaHunter Inc. and Attorney Hunter, an Attorney
Directory-Lawyers, Law Firms, Attorneys. Legal
Resources, Lawyer
Websites – Attorney Websites – Law Firm Websites – Legal
Websites designed by MegaHunter,
Inc. All Rights Reserved. |